Bioorganic and Medicinal Chemistry p. 1489 - 1496 (2019)
Update date:2022-08-02
Topics:
Liu, Qianqian
Li, Xia
Bao, Yong-Sheng
Lu, Jingxin
Li, Hua
Huang, Zhizhen
Liu, Feiyan
Deregulation of ceramide metabolism is a hallmark of human cancer. Ceramide analogues thereby represent a new class of anti-cancer agents. We aimed at developing effective and low toxic ceramide analogues and synthesized a new class of ceramide analogues starting from L-threonine. Several analogues exhibit potent cytotoxicity against human cancer cells in vitro with IC50 as low as 4.8 μM. These ceramide analogues decreased xIAP and Bcl-xL level and exhibited significant sensitization activity to overcome human cancer cell resistance to TRAIL, a cancer-selective agent that are being tested in human clinical trials. Furthermore, we determined that these ceramide analogues effectively suppress human cancer xenograft growth in vivo with no significant toxicity at the efficacious dose. Therefore, we have developed a simple and effective method to synthesize functional ceramide analogues using L-threonine as starting material and these analogues have the great potential to be further developed as anti-cancer agents in human cancer therapy.
View MoreContact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Nanjing Yuance Industry&Trade Co., Ltd.
website:http://www.njyuance.cn/
Contact:+86-25-85439097
Address:B1702, Aoti Bldg, No. 130, Aoti Avenue, Nanjing, China
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
shandong zhongke taidou chemical co.,ltd
Contact:86-531-88682301
Address:Jinan shandong Province CHina
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
Doi:10.1002/ejoc.201701502
(2018)Doi:10.1039/c3cc47426g
(2014)Doi:10.1016/j.dyepig.2014.04.004
(2014)Doi:10.1016/S0040-4020(01)85680-5
(1994)Doi:10.1021/acs.orglett.1c01103
(2021)Doi:10.1016/j.molstruc.2014.03.011
(2014)